Aquestive Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
Aquestive Therapeutics, Inc. (AQST) reported Stock Issued During Period, Shares, New Issues of 8.05 million shares for the 1-month period ending 2019-12-31, per its 10-Q filed 2020-11-04.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2020-11-04
- 2019-12-31: Stock Issued During Period, Shares, New Issues 1 month 8.05M shares.
- 2019-12-17: Stock Issued During Period, Shares, New Issues 8.05M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2019-12-31 | 8.05M shares 10-Q · filed 2020-11-04 | |
| 2019-12-17 | 8.05M shares 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |